Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity. (Q40470546)

20 September 2017

Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity. (English)

1 reference

Jacqueline de Vries-Idema

20 September 2017

0 references

0 references

series ordinal

4

object named as

Jacqueline de Vries-Idema

1 reference

20 September 2017

6

Toos Daemen

1 reference

20 September 2017

5

Jan Wilschut

1 reference

20 September 2017

2

Anke Huckriede

1 reference

20 September 2017

Laura Bungener

1

1 reference

PubMed ID

15652665

20 September 2017

Arjan de Mare

series ordinal

3

1 reference

PubMed ID

15652665

20 September 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

20 September 2017

1 reference

20 September 2017

23

1 reference

20 September 2017

10

1 reference

20 September 2017

1232-1241

1 reference

Vaccines against intracellular infections requiring cellular immunity.

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Role of viral infectivity in the induction of influenza virus-specific cytotoxic T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Generation, translocation, and presentation of MHC class I-restricted peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Cells process exogenous proteins for recognition by cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Cell-mediated lysis of heat-inactivated influenza virus-coated murine targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Dendritic cells and the control of immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

The cell biology of antigen presentation in dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Cross-presentation: a general mechanism for CTL immunity and tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Infectious entry pathway of influenza virus in a canine kidney cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Formation of virosomes from influenza subunits and liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Evaluation of viral membrane fusion assays. Comparison of the octadecylrhodamine dequenching assay with the pyrene excimer assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Preparation, properties, and applications of reconstituted influenza virus envelopes (virosomes).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Cellular cytoplasmic delivery of a polypeptide toxin by reconstituted influenza virus envelopes (virosomes).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Virosome-mediated delivery of protein antigens to dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Influenza virosomes in vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

A rapid and sensitive sub-micro phosphorus determination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

A simplification of the protein assay method of Lowry et al. which is more generally applicable

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Priming of cytotoxic T lymphocytes by five heat-aggregated antigens in vivo: conditions, efficiency, and relation to antibody responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Introduction of soluble protein into the class I pathway of antigen processing and presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Quantification of antigen specific CD8+ T cells using an ELISPOT assay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

pH sensitive liposomes provide an efficient means of sensitizing target cells to class I restricted CTL recognition of a soluble protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Characterization and kinetics of MHC class I-restricted presentation of a soluble antigen delivered by liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

The role of macrophages in the induction and regulation of immunity elicited by exogenous antigens

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

inferred from DOI database lookup

7 January 2021

based on heuristic

Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Monophosphoryl lipid A enhances specific CTL induction by a soluble protein antigen entrapped in liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

A mouse model for immunization with ex vivo virus-infected dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Capture and processing of exogenous antigens for presentation on MHC molecules.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Phagosomes are competent organelles for antigen cross-presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Helper activity is required for the in vivo generation of cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Help for cytotoxic-T-cell responses is mediated by CD40 signalling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Manipulating the immune system: humoral versus cell-mediated immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Dendritic cells: specialized and regulated antigen processing machines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.002

10.1016/J.VACCINE.2004.09.002

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

15652665